Pękala, A., Aebisher, D., Pardak, P. and Filip, R. 2019. Efficacy and safety of biosimilar IFX (CT-P13) and adalimumab in patients with active fistulizing perianal Crohn’s disease naďve to anti-TNF therapy: preliminary results from the POLIBD study. European Journal of Clinical and Experimental Medicine. 17, 1 (Mar. 2019), 12–15. DOI:https://doi.org/10.15584/ejcem.2019.1.2.